Align Technology operates in the healthcare sector and provides innovative solutions in the dental devices space. With a focus on clear aligners and scanners, the company has a strong presence globally. Its dual-segment approach targets both orthodontists and general dental practitioners offering potential for future growth.
The fundamental rating for Align Technology is solid, reflecting the company's robust financial health across various metrics.
Category | Score | Bar |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 4 | |
Return on Assets | 5 | |
Debt to Equity | 3 | |
Price to Earnings | 1 | |
Price to Book | 2 |
Analyzing the historical scores reveals slight changes in the company's financial indicators.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-05-23 | 3 | 4 | 4 | 5 | 3 | 1 | 2 |
Previous | 0 | 4 | 4 | 5 | 3 | 1 | 2 |
The analysts' price targets showcase diverse opinions, but the consensus reflects a steady belief in the stock's potential.
High | Low | Median | Consensus |
---|---|---|---|
$790 | $225 | $300 | $421 |
Current analyst recommendations indicate a strong tendency towards buying, with minimal sell sentiment.
Recommendation | Number of Analysts | Bar |
---|---|---|
Strong Buy | 0 | |
Buy | 24 | |
Hold | 5 | |
Sell | 1 | |
Strong Sell | 0 |
Align Technology demonstrates strong potential with growth in its core product segments. The stable financial indicators suggest a reliable investment opportunity, though the current valuation may be a concern for some investors. Analysts exhibit a favorable outlook for ALGN but caution is advised given the fluctuating market dynamics. Align’s innovative product lineup and expanding global presence remain key strengths driving future success.